ATG9A
Basic information
Region (hg38): 2:219219380-219229717
Previous symbols: [ "APG9L1" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ATG9A gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 37 | 38 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 37 | 1 | 1 |
Variants in ATG9A
This is a list of pathogenic ClinVar variants found in the ATG9A region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-219220778-G-A | not specified | Uncertain significance (Jan 18, 2023) | ||
2-219220880-A-C | not specified | Uncertain significance (Mar 22, 2023) | ||
2-219221098-G-A | not specified | Uncertain significance (Apr 05, 2024) | ||
2-219221143-G-A | not specified | Uncertain significance (Oct 05, 2023) | ||
2-219221200-C-G | not specified | Uncertain significance (Jan 04, 2022) | ||
2-219221208-C-T | not specified | Uncertain significance (May 05, 2023) | ||
2-219221227-T-C | not specified | Uncertain significance (Dec 21, 2022) | ||
2-219221254-G-A | not specified | Uncertain significance (Apr 07, 2023) | ||
2-219222273-C-T | not specified | Uncertain significance (May 27, 2022) | ||
2-219222311-G-A | not specified | Likely benign (Jan 10, 2023) | ||
2-219222341-C-T | not specified | Uncertain significance (Mar 29, 2024) | ||
2-219222390-T-C | not specified | Uncertain significance (Sep 01, 2021) | ||
2-219222435-C-T | not specified | Uncertain significance (Oct 17, 2023) | ||
2-219222695-G-A | not specified | Uncertain significance (Jan 17, 2023) | ||
2-219222727-G-A | not specified | Uncertain significance (Feb 15, 2023) | ||
2-219222736-C-T | not specified | Uncertain significance (Apr 20, 2023) | ||
2-219222809-T-C | not specified | Uncertain significance (Feb 02, 2022) | ||
2-219222875-T-C | not specified | Uncertain significance (Dec 14, 2021) | ||
2-219223590-G-C | not specified | Uncertain significance (May 30, 2024) | ||
2-219223605-G-A | not specified | Uncertain significance (Dec 13, 2022) | ||
2-219223608-C-T | not specified | Uncertain significance (Jul 20, 2021) | ||
2-219223679-A-G | not specified | Uncertain significance (May 02, 2024) | ||
2-219223886-G-A | not specified | Uncertain significance (Jun 16, 2024) | ||
2-219223972-C-T | not specified | Uncertain significance (Jul 26, 2021) | ||
2-219223994-A-C | not specified | Uncertain significance (Sep 01, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ATG9A | protein_coding | protein_coding | ENST00000409618 | 14 | 19946 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.971 | 0.0292 | 124778 | 0 | 16 | 124794 | 0.0000641 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.60 | 349 | 515 | 0.678 | 0.0000330 | 5431 |
Missense in Polyphen | 98 | 199.66 | 0.49083 | 2186 | ||
Synonymous | -0.417 | 217 | 209 | 1.04 | 0.0000132 | 1721 |
Loss of Function | 4.76 | 6 | 37.4 | 0.161 | 0.00000176 | 411 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000190 | 0.000187 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000556 | 0.0000556 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000821 | 0.0000794 |
Middle Eastern | 0.0000556 | 0.0000556 |
South Asian | 0.0000329 | 0.0000327 |
Other | 0.000165 | 0.000165 |
dbNSFP
Source:
- Function
- FUNCTION: Involved in autophagy and cytoplasm to vacuole transport (Cvt) vesicle formation. Plays a key role in the organization of the preautophagosomal structure/phagophore assembly site (PAS), the nucleating site for formation of the sequestering vesicle. Cycles between a juxta-nuclear trans-Golgi network compartment and late endosomes. Nutrient starvation induces accumulation on autophagosomes. Starvation-dependent trafficking requires ULK1, ATG13 and SUPT20H. {ECO:0000269|PubMed:16940348}.;
- Pathway
- Autophagy - animal - Homo sapiens (human);Autophagy - other - Homo sapiens (human);Mitophagy - animal - Homo sapiens (human);miR-targeted genes in epithelium - TarBase;miR-targeted genes in lymphocytes - TarBase;miR-targeted genes in muscle cell - TarBase
(Consensus)
Recessive Scores
- pRec
- 0.110
Intolerance Scores
- loftool
- 0.219
- rvis_EVS
- -0.35
- rvis_percentile_EVS
- 29.49
Haploinsufficiency Scores
- pHI
- 0.165
- hipred
- Y
- hipred_score
- 0.639
- ghis
- 0.542
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.559
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Atg9a
- Phenotype
- cellular phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); immune system phenotype;
Gene ontology
- Biological process
- autophagosome assembly;autophagy of mitochondrion;protein transport;protein localization to phagophore assembly site;late nucleophagy
- Cellular component
- phagophore assembly site;autophagosome membrane;endosome;late endosome;autophagosome;endoplasmic reticulum membrane;trans-Golgi network;membrane;integral component of membrane;late endosome membrane;intracellular membrane-bounded organelle;recycling endosome
- Molecular function
- protein binding